Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy3 maleimide non sulfonated 25mg'

Search results for: 'cy3 maleimide non sulfonated 25mg'

Items 51-60 of 139

Page
per page
  1. BMS 599626 dihydrochloride
    B5792 BMS 599626 dihydrochloride
    Summary: EGFR and ErbB2 inhibitor,potent and selective
      Soluble in DMSO
  2. XL228
    A3939 XL228
    Summary: IGF1R/AURORA /FGFR1-3/ABL/SRC family kinases inhibitor
      ≥21.9 mg/mL
  3. Vandetanib (ZD6474)
    A8555 Vandetanib (ZD6474)
    Target: VEGFR|EGFR
    Summary: VEGFR2/EGFR antagonist
      insoluble in H2O; ≥11.88 mg/mL
  4. FIIN-2
    A8696 FIIN-2
    Target: FGFR
    Summary: Irreversible inhibitor of FGFR
      ≥31.75 mg/mL
  5. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  6. Flumatinib mesylate
    A8691 Flumatinib mesylate
    Summary: PDGRFβ inhibitor
      Soluble in DMSO
  7. PF-04217903 methanesulfonate
    A3712 PF-04217903 methanesulfonate
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      Soluble in DMSO
  8. GZD824
    B1402 GZD824
    Target: Bcr-Abl
    Summary: Bcr-Abl inhibitor,novel orally bioavailable
      ≥36.25 mg/mL
  9. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: orally bioavailable dual MER/FLT3 inhibitor
      ≥23.85 mg/mL
  10. PRT-060318
    B6161 PRT-060318
    Summary: novel Syk inhibitor
      Soluble in DMSO

Items 51-60 of 139

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 8item
  2. Axl 3item
  3. ALK 8item
  4. Broad Spectrum Protein Kinase Inhibitor 2item
  5. c-Kit 3item
  6. c-MET 13item
  7. CSF-1R 1 item
  8. EGFR 26item
  9. FAK 4item
  10. FGFR 7item
  11. FLT3 7item
  12. HER2 6item
  13. IGF1R 5item
  14. Insulin Receptor 1 item
  15. LRRK2 4item
  16. PDGFR 9item
  17. PTKs/RTKs 1 item
  18. Pyk2 2item
  19. ROR 4item
  20. Spleen Tyrosine Kinase (Syk) 6item
  21. Src 9item
  22. Tie-2 2item
  23. Trk 3item
  24. VEGFR 26item
Specificity
  1. Selective 55item
Reversibility
  1. Reversible 6item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 1 item
  3. CSF-1R 3item
  4. MER 1 item
  5. FLT3 6item
  6. VEGFR 18item
  7. PDGFR 13item
  8. c-Kit 4item
  9. RET 1 item
  10. Bcr-Abl 6item
  11. FGFR 10item
  12. MET 4item
  13. Src 8item
  14. Trk Receptors 3item
  15. STAT 1 item
  16. EGFR 11item
  17. FAK 3item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 2item
  20. Syk 4item
  21. ErbB 2item
  22. c-MET 5item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. Lyn 2item
  26. Pyk2 3item
  27. LRRK2 3item
  28. Insulin and Insulin-like Receptors 1 item
  29. ALK 3item
  30. ROS1 2item
  31. Angiotensin-Converting Enzymes (ACEs) 1 item
  32. Tie-2 2item
  33. c-Fyn 1 item
  34. 5-Lipoxygenases 1 item
  35. Insulin Receptors 1 item
  36. IRG-1R 1 item
  37. ZAP-70 1 item
  38. TAM kinase 1 item
  39. insulin 1 item
  40. PTK 1 item
  41. Flk1 1 item
  42. YES 1 item
  43. Fyn 1 item
  44. enoyl-acyl-carrier protein reductase 1 item
  45. tropomyosin receptor kinase 1 item
  46. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 66item
  2. Cell Experiments 44item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 1 item
  6. Breast Cancer 11item
  7. Cancer 49item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 2item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 5item
  13. Glioblastoma 1 item
  14. Glioma 3item
  15. Hepatocellular Carcinoma 3item
  16. Leukemia 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 3item
  19. Lymphoma 1 item
  20. Multiple Myeloma 3item
  21. Neuroblastoma 1 item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 4item
  24. Pancreatic Cancer 7item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 2item
  29. Thyroid Cancer 1 item